The table below shows CORCEPT THERAPEUTICS INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$142.00M
$198.29M
$126.68M
$120.32M
$167.89M
$151.97M
Capital expenditure
$211.00K
$2.17M
$139.00K
$413.00K
$469.00K
$1.24M
Investing cash flow
$69.76M
-$177.60M
$90.91M
-$114.33M
$136.13M
-$119.26M
Dividends paid
-
-
-
-
-
-
CORT operating cash flow (10-K history)
CORCEPT THERAPEUTICS INC reported operating cash flow of $142.00M for fiscal year 2025. That is down 28.4% from $198.29M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $18.39M (FY 2016) to $142.00M. Figures come from the company's audited annual reports as filed with the SEC.
